2006
DOI: 10.1378/chest.130.6.1679
|View full text |Cite
|
Sign up to set email alerts
|

Overdiagnosis of Asthma and Its Relationship to Body Mass Index

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(9 citation statements)
references
References 26 publications
0
8
0
1
Order By: Relevance
“…Despite recent advances in medical care, invasive Group A Streptococcus-induced NF patients have high mortality rates (ranging from 18% to 34%) [32,33]. The reported rates of bacteremia with Group A streptococci range from 46 to 85% [34-36]. Our results showed that patients with Group A Streptococcus in blood cultures had significantly higher mortality rates when compared with patients negative for Group A Streptococcus .…”
Section: Discussionmentioning
confidence: 60%
“…Despite recent advances in medical care, invasive Group A Streptococcus-induced NF patients have high mortality rates (ranging from 18% to 34%) [32,33]. The reported rates of bacteremia with Group A streptococci range from 46 to 85% [34-36]. Our results showed that patients with Group A Streptococcus in blood cultures had significantly higher mortality rates when compared with patients negative for Group A Streptococcus .…”
Section: Discussionmentioning
confidence: 60%
“…Patients with iGAS diseases typically have either low titers, or lack antibodies to the causative GAS serotype suggesting that sufficient levels of circulating antibodies may protect against iGAS diseases [45,46]. Intravenous immunoglobulin (IVIG) contains both opsonic and neutralizing antibodies to several GAS virulence factors [47][48][49][50][51][52]. There has been some clinical success using IVIG to treat iGAS diseases, especially streptococcal toxic shock syndrome [51,53,54]; however, definitive results from robust clinical trials are lacking [55,56].…”
Section: Plos Onementioning
confidence: 99%
“…Though it has been emphasized that severe or invasive disease can develop in anyone, GAS infections, like other bacterial diseases in general, progress in patients with underlying chinks in their defenses. Intact humoral immunity plays a very important role in preventing and combating GAS infections (17). Extremes of age (less than 2 or greater than 65), concurrent acute viral infection, preexisting skin/soft tissue lesions, diabetes mellitus, heart disease, chronic obstructive pulmonary disease, underlying malignancy, and immune suppression from HIV infection or corticosteroids are all associated with increased risk of infection and progression to invasive disease (5,6,8,9,11,16,18).…”
Section: Who Is At Higher Risk For Invasive/severe Infection?mentioning
confidence: 99%